FY19 Ad Hoc Programmatic Reviewers :

David Ashley, Ph.D.
Duke University

Lamia Barakat, Ph.D.
Children’s Hospital of Philadelphia

Sebastiano Battaglia, Ph.D.
Roswell Park Cancer Institute

Adrienne Boire, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center

Daniel Cahill, M.D., Ph.D.
Massachusetts General Hospital

Woonyoung Choi, Ph.D.
Johns Hopkins University

Jaydira Del Rivero, M.D.
National Cancer Institute

Christine Eischen, Ph.D.
Thomas Jefferson University

Mark Frey, Ph.D.
Keck School of Medicine, University of Southern California

Bryan Fuchs, Ph.D.
Ferring Pharmaceuticals

LCDR Michelle Gage, M.D.
John P. Murtha Regional Cancer Center

Richard Goldberg, M.D.
West Virginia University

Bob Halinski (Consumer)
Mary Halinski Pancreatic Research Fund

Donna Hansel, M.D., Ph.D.
Oregon Health and Science University Foundation

James Randolph Hillard, M.D. (Consumer)
Debbie’s Dream Foundation

LeAnn Jackson (Consumer)
Pediatric Brain Tumor Consortium Foundation

Razelle Kurzrock, M.D.
University of California San Diego Health

Rosa Lapalombella, Ph.D.
Ohio State University

Michael Pishvaian, M.D., Ph.D.
Georgetown University

Osama Rahma, M.D.
Dana-Farber Cancer Institute

Andrea Reid, M.D.
Washington D.C. Veterans Affairs Medical Center

Deepak Saxena, Ph.D.
New York University

LTC Robert Setlik, M.D.
Brooke Army Medical Center

Rainer Storb, M.D.
Fred Hutchinson Cancer Research Center

Stephanie Terezakis, M.D.
University of Minnesota

LTC Michael Wiggins, M.D.
William Beaumont Army Medical Center

Wei Zhou, Ph.D.
Emory University